The findings highlighted the pivotal role of serum VEGF-D in LAM pathophysiology and underscore that age, TSC, retroperitoneal LAM, chylous effusion, AMLs, and high HRCT grade were independent risk factors for increased VEGF-D levels. The gene discussed is VEGFD; the disease is lymphangioleiomyomatosis.